≤3 cm 肺浸润性腺癌中微乳头与实性亚型次要成分的 PET/CT 表现及其与淋巴结转移的相关性
本研究纳入 506 例 ≤3 cm 的肺浸润性腺癌患者,按实性/微乳头成分比例分为阴性组(258 例)、次要成分组(158 例)和主要成分组(90 例),比较各组 PET/CT 表现。结果显示主要成分组 SUVmax、MTV、TLG 及肿瘤大小最高,其次为次要成分组和阴性组(P < 0.001);SUVmax、MTV、TLG 诊断淋巴结转移的 AUC 分别为 0.822、0.843、0.835;次要成分组和主要成分组淋巴结转移均多于阴性组(P < 0.001)。
要点
- 实性/微乳头成分即使不是主要成分,也伴随更高的 SUVmax、MTV、TLG 和肿瘤大小。
- SUVmax、MTV、TLG 诊断淋巴结转移的 AUC 分别为 0.822、0.843、0.835。
- 次要成分组和主要成分组淋巴结转移均多于阴性组(P < 0.001)。
关键影像表现/征象
- SUVmax、MTV、TLG 和肿瘤大小在主要成分组最高,其次为次要成分组和阴性组(P < 0.001)。
- 淋巴结转移组 CEA、SUVmax、MTV、TLG、肿瘤大小及胸膜侵犯均更高(P < 0.001)。
诊断标准与关键数值
- SUVmax、MTV、TLG 诊断淋巴结转移的 AUC 分别为 0.822、0.843、0.835。
- 单因素分析显示次要成分组和主要成分组淋巴结转移均多于阴性组(P < 0.001)。
- Logistic 回归显示主要成分病理类型、次要成分病理类型、较高 CEA 和男性为淋巴结转移的危险因素(P < 0.01)。
临床应用与阅片要点
- 阅片时即使实性/微乳头成分仅为次要成分(>5% 但非主要),也应记录并提示其与淋巴结转移相关。
- 可结合 SUVmax、MTV、TLG 及肿瘤大小评估淋巴结转移风险,AUC 分别为 0.822、0.843、0.835。
- 报告时注意结合 CEA 水平和患者性别等临床因素综合判断淋巴结转移风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the PET/CT findings in lung invasive adenocarcinoma with minor components of micropapillary or solid contents and its association with lymph node metastasis.
MATERIALS AND METHODS: A total of 506 lung invasive adenocarcinoma (≤ 3 cm) patients who underwent a PET/CT examination and resection surgery were included. According to the proportion of solid/micropapillary components, the patients were classified into three groups: solid/micropapillary-negative (SMPN) (n = 258), solid/micropapillary-minor (SMPM; > 5% not predominant) (n = 158) and solid/micropapillary-predominant (SMPP; > 5% most dominant) (n = 90). The patients' PET/CT findings, including SUVmax, MTV, TLG and CT characteristics, and other clinical factors were compared by one-way ANOVA test. Logistic regression analysis was done to identify the most predictive findings for lymph node metastasis.
RESULTS: The value of SUVmax, MTV, TLG and tumor size was highest in SMPP group, followed by SMPM and SMPN group (P < 0.001).The areas under the curve for SUVmax, MTV and TLG for node metastasis were 0.822, 0.843 and 0.835, respectively. Univariate analysis found that the SMPP and SMPM group had more lymph node metastasis than the SMPN group (P < 0.001). Furthermore, the lymph node metastasis group had higher CEA, SUVmax, MTV, TLG, tumor size and more pleural invasion (P < 0.001). Logistic regression analysis found that SMPP pathological type, SMPM pathological type, higher CEA and male patients were risk factors for lymph node metastasis (P < 0.01).
CONCLUSIONS: Lung invasive adenocarcinoma with micropapillary or solid contents had higher SUVmax, MTV, TLG and tumor size and was associated with lymph node metastasis, even if they were not predominant.
引用
- Chang C, Sun X, Zhao W, et al. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis. Radiol Med. 2019. PMID: 31823295. doi:10.1007/s11547-019-01112-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。